Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-020765

AVEO PHARMACEUTICALS INC · AVEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael N Needle
Officer — Chief Medical Officer
Period of report
Aug 17, 2017
Accepted (ET)
Aug 21, 2017 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 17, 2017J25,907$0.00D25,906D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Warrants (right to buy)F2$1.00Aug 17, 2017J25,907D—May 17, 2021Common Stock25,90725,906D
Stock Option (right-to-buy)F4$1.07Aug 17, 2017J205,729D—Feb 3, 2025Common Stock205,729500,000D
Stock Option (right to buy)F6$1.08Aug 17, 2017J67,889D—Jan 7, 2026Common Stock67,889184,000D

Explanation of responses